Stay updated with breaking news from Neither Johnson. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Enhances Johnson & Johnson’s Ability to Transform the Treatment Landscape for Cardiovascular Disease and Continue to Improve Patient Outcomes Extends Johnson & Johnson MedTech’s Position in...
TECNIS PureSee IOL TECNIS PureSee Next-generation lens features purely refractive design, delivering uninterrupted high-quality vision LIMERICK, IRELAND, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Johnson & Johnson MedTech*, a global leader in eye health, announced today that its TECNIS PureSee purely refractive presbyopia-correcting lens is now available in EMEA. The TECNIS PureSee IOL features a proprietary, purely refractive design that delivers uninterrupted, high-quality, vision with high best-in-ca
Next-generation lens features purely refractive design, delivering uninterrupted high-quality vision LIMERICK, IRELAND, Feb. 15, 2024 (GLOBE...
Portfolio of Clinical and Preclinical Programs, Including Lead Product Candidate ARX517, a Prostate-Specific Membrane Antigen -Targeting Antibody Drug Conjugate , Strengthens Johnson & Johnson's...
Innovative investigational device designed for Left Atrial Appendage Elimination to reduce the risk of stroke in patients with non-valvular atrial fibrillation Strengthens position in high-growth...